Page last updated: 2024-08-24

zolmitriptan and Recrudescence

zolmitriptan has been researched along with Recrudescence in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (45.00)	18.2507
2000's	11 (55.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuuchi, Y; Itoyama, Y; Iwata, M; Morimatsu, M; Nakashima, K; Sakai, F; Sobue, G; Tashiro, K; Tsuji, S	1
Stöckli, HR; Sword, A	1
Brandes, J; Dodick, D; Elkind, A; Mathew, N; Rodichok, L	1
Bendtsen, L; Daugaard, D; Dixon, R; Gibbens, M; Langemark, M; Lassen, LH; Olesen, J; Thomsen, LL	1
Dahlöf, C	1
Adelman, JU; Earl, NL; Elkind, AH; Kudrow, DB; Mathew, NT; Ramadan, NM; Rapoport, AM	1
Sawyer, J; Schoenen, J	1
Lipton, RB; Stewart, WF	1
Deleu, D; Hanssens, Y	1
Bomhof, MA; Donnan, GA; Dowson, AJ; Elkind, A; Fletcher, PE; Meloche, J; Millson, DS; Tepper, SJ	1
Farkkila, M; Hering-Hanit, R; Mauskop, A; Rapoport, A; Warner, J	1
Logemann, CD; Rankin, LM	1
Chitra, R; Dennish, G; Gallagher, RM; Spierings, EL	1
Diener, HC; Geraud, G; Olesen, J; Pfaffenrath, V; Sweet, R; Tfelt-Hansen, P; Zupping, R	1
Allen, C; Diener, HC; Pascual, J; Patel, K; Vega, P; Vrijens, F	1
Potrebic, S; Raskin, NH	1
Gruffyd-Jones, K; Kies, B; Middleton, A; Millson, DS; Mulder, LJ; Røsjø , Ø	1
Billeter, M; Daems, K; Sturzenegger, M	1
Becker, WJ; Dowson, AJ; Green, J; Levy, SL; MacGregor, EA; Purdy, RA	1

Reviews

4 review(s) available for zolmitriptan and Recrudescence

Article	Year
Clinical applications of zolmitriptan (Zomig, 311C90). Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Acute Disease; Disabled Persons; Dose-Response Relationship, Drug; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tryptamines	1997
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Acta neurologica Belgica, 1999, Volume: 99, Issue:2 Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents	1999
Newer intranasal migraine medications. American family physician, 2000, Jan-01, Volume: 61, Issue:1 Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines	2000
New abortive agents for the treatment of migraine. Advances in internal medicine, 2001, Volume: 46 Topics: Clinical Trials as Topic; Female; Humans; Indoles; Male; Migraine Disorders; Oxazolidinones; Piperidines; Prognosis; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines	2001

Trials

13 trial(s) available for zolmitriptan and Recrudescence

Article	Year
Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:5 Topics: Adult; Cultural Characteristics; Dose-Response Relationship, Drug; Female; Humans; Hyperacusis; Japan; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Photophobia; Recurrence; Safety; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines; Vomiting	2002
[Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study]. Praxis, 2003, Feb-26, Volume: 92, Issue:9 Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pain Measurement; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Tablets; Time Factors; Tryptamines	2003
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS drugs, 2005, Volume: 19, Issue:2 Topics: Administration, Intranasal; Adolescent; Adult; Aged; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pain Measurement; Reaction Time; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines	2005
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group. Neurology, 1997, Volume: 49, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tryptamines	1997
Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy. Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 18 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Female; Humans; Menstruation; Middle Aged; Migraine Disorders; Nausea; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group. Headache, 1998, Volume: 38, Issue:3 Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tryptamines	1998
A long-term study to maximise migraine relief with zolmitriptan. Current medical research and opinion, 1999, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Tablets; Time Factors; Tryptamines	1999
Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache. Current medical research and opinion, 1999, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Time Factors; Tryptamines	1999
A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache, 2000, Volume: 40, Issue:2 Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Patient Satisfaction; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Tryptamines	2000
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Research Design; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2000
Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:5 Topics: Adult; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Oxazolidinones; Quality of Life; Recurrence; Retreatment; Serotonin Receptor Agonists; Time Factors; Triazoles; Tryptamines	2000
Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. European journal of neurology, 2001, Volume: 8, Issue:3 Topics: Administration, Oral; Adult; Double-Blind Method; Female; Humans; International Cooperation; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Tryptamines	2001
Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:2 Topics: Administration, Oral; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Palliative Care; Patient Satisfaction; Recurrence; Retreatment; Serotonin Receptor Agonists; Solubility; Tryptamines	2002

Other Studies

3 other study(ies) available for zolmitriptan and Recrudescence

Article	Year
311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attack and in a migraine-free period. Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:4 Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Time Factors; Tryptamines	1996
Would any acute treatment for migraine demonstrate recurrence? Cephalalgia : an international journal of headache, 1997, Volume: 17 Suppl 17 Topics: Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	1997
[Zolmitriptan in treatment of migraine attack--the ARES Study]. Schweizerische medizinische Wochenschrift, 2000, Dec-23, Volume: 130, Issue:51-52 Topics: Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pain Measurement; Recurrence; Treatment Outcome; Tryptamines	2000